KEGG: sce:YDR275W
STRING: 4932.YDR275W
BSC2 (Bypass of Stop Codon protein 2) is a protein in Saccharomyces cerevisiae that plays multiple roles in cellular function. Originally identified through screening of gene deletion strains that affect premature stop codon bypass, BSC2 has been found to be important for cytoplasmic protein biosynthesis . More recent research has revealed its significant role in antioxidation processes and drug resistance mechanisms. The protein consists of 235 amino acids and has been successfully expressed as a recombinant protein with N-terminal His-tag fusion in E. coli expression systems .
BSC2 was identified through systematic screening of gene deletion strains that affect premature stop codon bypass in yeast. Researchers used expression plasmids (pUKC817, pUKC818, and pUKC819) containing different premature stop codons (UAA, UGA, and UAG, respectively) within a LacZ expression cassette to identify genes affecting translation termination. The deletion of BSC2 altered the efficiency of stop codon bypass, suggesting its involvement in translation fidelity maintenance. This identification process utilized large-scale β-galactosidase assays to evaluate the production of β-galactosidase in each gene deletion strain, with pUKC815 carrying the native LacZ gene as a control .
Recombinant BSC2 is typically produced using E. coli expression systems for in vitro studies. For functional characterization within yeast cells, researchers employ both plasmid-based expression vectors and chromosomal integration approaches in S. cerevisiae. When expressing BSC2 in S. cerevisiae, the full-length protein (amino acids 1-235) can be fused with tags such as His-tag for purification and detection purposes . For chromosomal integration, researchers often select high-expression loci to ensure consistent expression levels. Comparative studies have shown that multicopy BSC2-expression vectors typically yield higher protein levels compared to single-copy chromosomal integrations, resulting in more pronounced phenotypic effects .
For BSC2 expression manipulation in S. cerevisiae, researchers can employ multiple strategies:
Plasmid-based overexpression:
Use multicopy plasmids with constitutive promoters (e.g., TEF1, TDH3) for high-level expression
Use centromeric plasmids (CEN plasmids) for moderate expression levels
Employ inducible promoters (GAL1, CUP1) for controlled expression timing
Genomic integration:
Single-copy integration at high-expression loci for stable expression
CRISPR-Cas9 mediated gene editing for precise modifications
Gene deletion:
Create knockout strains using homologous recombination techniques
Use marker-based selection systems (e.g., URA3, LEU2) for screening
Comparative analysis has shown that multicopy BSC2 expression vectors in CEN.PK strain (CEN.PK-btrC) produce significantly higher protein levels than single-copy genomic integrations, with approximately 11-fold higher expression levels as measured by specific protein detection methods .
To assess BSC2's role in multidrug resistance, implement the following experimental approach:
Strain preparation:
Generate BSC2 deletion strains (bsc2Δ)
Create BSC2 overexpression strains using multicopy plasmids
Develop complementation strains with controlled BSC2 expression
Drug susceptibility testing:
Perform spot assays on solid media containing various antifungal agents:
Amphotericin B (AMB)
Fluconazole (FLC)
Chlorhexidine (CHX)
5-Fluorocytosine (5-FC)
Caspofungin (CAS)
Growth inhibition measurement:
Conduct liquid culture growth assays with varying drug concentrations
Calculate IC50 values to quantify resistance levels
Genetic interaction studies:
Test BSC2 function in various genetic backgrounds
Pay particular attention to FLO pathway mutants (FLO11Δ, FLO1Δ, FLO8Δ, TUP1Δ)
Research has demonstrated that BSC2 overexpression confers resistance to multiple antifungal compounds, while bsc2Δ strains show increased sensitivity compared to wild-type. The degree of resistance varies between drugs, with particularly strong effects observed for AMB and CAS .
To investigate BSC2's effects on biofilm formation, employ the following methodological approaches:
Flocculation assessment:
Measure sedimentation rates in culture tubes
Quantify flocculation using spectrophotometric methods
Compare wild-type, bsc2Δ, and BSC2-overexpression strains
Cell surface hydrophobicity (CSH) analysis:
Implement hydrocarbon adherence assays
Measure water contact angles on cell lawns
Calculate hydrophobicity indices
Biofilm formation quantification:
Grow biofilms on appropriate surfaces (polystyrene, glass)
Stain with crystal violet for biomass quantification
Use confocal microscopy for structural analysis
Implement fluorescent labeling for viability assessment
Invasive growth evaluation:
Plate cultures on appropriate agar media
Wash plate surface and photograph remaining colonies
Quantify invasion depth using microscopy
Test in conjunction with FLO pathway mutants
Experimental data has shown that BSC2-overexpression strains exhibit enhanced flocculation, increased cell surface hydrophobicity, and more robust biofilm formation compared to control strains. These phenotypic changes are dependent on functional FLO pathway components, as BSC2 overexpression fails to induce these changes in FLO pathway mutants .
BSC2 regulates biofilm formation and subsequent drug resistance through complex interactions with the FLO pathway. Mechanistically, BSC2 overexpression significantly increases the mRNA expression of key FLO genes, including FLO11, FLO1, FLO8, and TUP1 . This transcriptional upregulation leads to enhanced cellular flocculation, increased cell surface hydrophobicity, and robust biofilm development.
The relationship between BSC2 and the FLO pathway is hierarchical, with BSC2 functioning upstream as a regulator. This is evidenced by the inability of BSC2 overexpression to induce caspofungin (CAS) resistance or affect invasive growth in FLO pathway mutants (FLO11Δ, FLO1Δ, FLO8Δ, and TUP1Δ) . Different FLO genes contribute distinctly to the resistance phenotype, with FLO8Δ and FLO11Δ strains exhibiting CAS resistance, while FLO1Δ and TUP1Δ strains show CAS sensitivity, indicating that biofilm formation alone is insufficient for multidrug resistance (MDR) .
The regulatory mechanism appears to involve cell wall remodeling, as BSC2 overexpression increases mannose content in the cell wall and compensates for chitin synthesis defects, contributing to cell wall integrity maintenance. This cell wall modification likely contributes to the drug resistance phenotype by limiting drug penetration and activating stress response pathways .
The dual functionality of BSC2 in both translation fidelity (stop codon bypass) and multidrug resistance presents an intriguing research question. While direct experimental evidence linking these two functions is limited, several hypothetical mechanisms can be proposed:
Stress response integration: Both translation fidelity and drug resistance mechanisms may be interconnected components of the cellular stress response. BSC2 might serve as a regulatory node that coordinates these responses.
Proteome remodeling: Alterations in stop codon bypass efficiency could modify the cellular proteome, potentially including proteins involved in drug resistance pathways. This could include increased readthrough of premature stop codons in genes relevant to drug efflux or detoxification.
Translational control of resistance factors: BSC2 might specifically regulate the translation of mRNAs encoding proteins involved in drug resistance, biofilm formation, or cell wall biosynthesis.
The genetic screening that identified BSC2 as affecting stop codon bypass utilized plasmids containing premature stop codons within a LacZ expression cassette, allowing quantitative assessment of bypass efficiency through β-galactosidase activity . Complementary approaches examining translation fidelity in strains with altered drug resistance profiles could help elucidate the connection between these functions.
BSC2 plays a crucial role in maintaining cell wall integrity and normal morphology in S. cerevisiae through several mechanisms:
Chitin synthesis modulation: BSC2 overexpression compensates for chitin synthesis defects, helping maintain cell wall structural integrity. This was demonstrated by the ability of BSC2 overexpression to significantly reduce cell morphology abnormalities induced by caspofungin (CAS), an echinocandin antifungal that inhibits β-1,3-glucan synthesis .
Mannose content regulation: BSC2 overexpression increases mannose levels in the cell wall, potentially modifying cell wall architecture and permeability. This effect appears mechanistically linked to DPM1 (dolichol phosphate mannose synthase), as DPM1 overexpression in both wild-type and bsc2Δ backgrounds conferred resistance to CAS and AMB .
FLO pathway-dependent regulation: BSC2's effects on cell wall integrity are dependent on a functional FLO pathway, as BSC2 overexpression failed to repair cell wall damage caused by CAS in FLO mutant strains. This suggests that BSC2 regulates cell wall integrity at least partially through the FLO pathway components .
Biofilm matrix contributions: The enhanced biofilm formation associated with BSC2 overexpression likely includes extracellular matrix components that contribute to both community structure and protection from environmental stressors, including antifungal drugs .
These functions collectively suggest that BSC2 serves as an important regulatory factor in cellular responses to cell wall stress, potentially coordinating transcriptional and translational responses to maintain cellular integrity under challenging conditions.
When investigating BSC2's diverse functions, researchers should implement targeted experimental designs that can isolate specific aspects of its activity:
Domain mapping and mutational analysis:
Create truncated or point-mutated versions of BSC2
Test each variant for specific functions (translation, drug resistance, biofilm formation)
Identify domains critical for each function
Use complementation assays in bsc2Δ strains to validate domain functions
Temporal control strategies:
Employ inducible expression systems (e.g., GAL1 promoter)
Implement rapid protein degradation systems (auxin-inducible degron)
Monitor different cellular processes during BSC2 expression/depletion time courses
Correlate BSC2 levels with phenotypic changes
Pathway-specific reporters:
Develop reporters for translation fidelity (stop codon readthrough)
Create biofilm formation reporters linked to FLO gene expression
Implement cell wall integrity pathway reporters
Monitor multiple pathways simultaneously during BSC2 manipulation
Genetic suppressor/enhancer screens:
Identify mutations that suppress or enhance specific BSC2-dependent phenotypes
Use genome-wide approaches (synthetic genetic array analysis)
Focus on genes with known functions in relevant pathways
These approaches can help distinguish between direct and indirect effects of BSC2 on various cellular processes, clarifying whether its multiple functions represent independent activities or interconnected aspects of a unified cellular role .
To thoroughly characterize BSC2-mediated changes in cell wall composition, researchers should employ multiple complementary analytical approaches:
Compositional analysis:
Quantify β-1,3-glucan content using aniline blue staining and fluorescence spectroscopy
Measure chitin levels using calcofluor white staining and flow cytometry
Determine mannose content through acid hydrolysis followed by HPLC analysis
Compare cell wall fractions between wild-type, bsc2Δ, and BSC2-overexpression strains
Structural characterization:
Implement atomic force microscopy (AFM) for cell wall surface topography
Use transmission electron microscopy (TEM) to measure cell wall thickness and layering
Apply scanning electron microscopy (SEM) for surface feature analysis
Perform mechanical property testing using single-cell compression devices
Functional assessments:
Test susceptibility to cell wall-perturbing agents (congo red, calcofluor white)
Measure osmotic stress tolerance
Evaluate resistance to cell wall-degrading enzymes (β-glucanase, chitinase)
Assess cell wall permeability using fluorescent dye uptake assays
Molecular interactions:
Identify cell wall proteins with altered abundance or localization
Analyze protein glycosylation patterns
Study mannoproteins using lectin binding assays
Investigate protein-polysaccharide associations
Research has shown that BSC2 overexpression increases mannose content in the cell wall and compensates for chitin synthesis defects, suggesting a specific role in regulating these components of cell wall architecture . Comprehensive cell wall analysis will help elucidate the molecular mechanisms underlying these effects.
Distinguishing direct from indirect effects of BSC2 on multidrug resistance requires sophisticated experimental approaches:
Temporal analysis of gene expression:
Implement time-course RNA-seq after BSC2 induction
Identify immediate early response genes versus secondary effects
Compare expression profiles in different genetic backgrounds
Correlate gene expression changes with development of resistance
Pathway dissection:
Test BSC2 effects in strains lacking specific resistance mechanisms
Analyze drug transport (efflux pump activity, drug uptake assays)
Measure reactive oxygen species (ROS) levels and oxidative stress responses
Evaluate cell wall permeability changes separately from other resistance mechanisms
Protein interaction studies:
Perform co-immunoprecipitation to identify BSC2 binding partners
Use yeast two-hybrid or proximity labeling approaches
Conduct epistasis analysis with genes in relevant pathways
Implement ChIP-seq to identify potential transcriptional targets
Direct measurement of drug interactions:
Quantify intracellular drug concentrations in different strains
Analyze drug binding to cellular targets
Implement fluorescently labeled drug analogs for localization studies
Compare biochemical drug targets in wild-type versus BSC2-modified strains
When analyzing complex phenotypic data related to BSC2 function, appropriate statistical methods are crucial:
For drug susceptibility testing:
Apply dose-response curve analysis with non-linear regression
Calculate and compare IC50 values with 95% confidence intervals
Implement two-way ANOVA to evaluate strain and drug interactions
Use repeated measures approaches for time-course experiments
For biofilm quantification:
Apply appropriate data transformations to achieve normality
Implement mixed-effects models for multi-plate/batch experiments
Use non-parametric methods for non-normally distributed data
Apply multivariate analysis for multiple biofilm parameters
For gene expression data:
Implement false discovery rate (FDR) correction for multiple testing
Use principal component analysis for pattern identification
Apply hierarchical clustering to identify co-regulated gene groups
Implement pathway enrichment analysis to identify biological processes
For phenotypic correlations:
Calculate Spearman's rank correlation between different phenotypes
Apply multidimensional scaling to visualize relationships
Implement factor analysis to identify underlying variables
Use machine learning approaches for complex pattern recognition
When reporting results, researchers should include both statistical significance (p-values) and effect sizes, as the biological relevance of BSC2-mediated changes may not always correlate with statistical significance alone. Additionally, visualization methods that effectively communicate complex relationships between multiple variables should be employed .
Contradictory findings regarding BSC2 function may arise from various experimental factors. Researchers should consider the following approaches for reconciliation:
Strain background evaluation:
Compare genetic backgrounds used in different studies
Test BSC2 function across multiple strain backgrounds
Consider genome-wide variation and potential genetic interactions
Examine strain-specific phenotypes that might influence BSC2 function
Expression level considerations:
Quantify BSC2 expression levels in different experimental systems
Create standardized expression constructs for cross-study comparisons
Develop dose-response relationships between BSC2 levels and phenotypes
Consider potential threshold effects or non-linear relationships
Environmental condition analysis:
Compare growth media, temperature, pH, and other environmental factors
Test BSC2 function across a range of controlled conditions
Examine stress-specific responses versus general functions
Implement factorial experimental designs to identify condition interactions
Methodological standardization:
Develop standard operating procedures for key assays
Implement both the original and new methodologies in parallel
Consider sensitivity and specificity of different detection methods
Use multiple complementary approaches to measure the same phenotype
For example, research has shown that BSC2's effects on drug resistance depend on a functional FLO pathway, which might explain discrepancies in resistance profiles observed in studies using different strain backgrounds with variations in FLO gene functionality. Additionally, the degree of BSC2 overexpression appears critical, with multicopy expression systems showing much stronger phenotypes than single-copy integrations .
To gain deeper insights into BSC2 function through bioinformatics:
Structural analysis:
Predict protein structure using AlphaFold or similar tools
Identify functional domains and motifs
Perform molecular dynamics simulations to study conformational changes
Analyze potential binding sites for ligands or protein partners
Comparative genomics:
Conduct comprehensive ortholog identification across fungal species
Examine synteny and genomic context conservation
Analyze selection pressure (dN/dS ratios) across domains
Investigate potential horizontal gene transfer events
Interactome prediction:
Build protein-protein interaction networks from experimental and predicted data
Identify functional clusters and pathways
Predict genetic interactions using machine learning approaches
Integrate transcriptomic data to create condition-specific networks
Evolutionary analysis:
Construct phylogenetic trees of BSC2 across fungal species
Identify lineage-specific functional adaptations
Correlate BSC2 sequence changes with phenotypic traits
Examine co-evolution with interacting partners
Several cutting-edge technologies hold promise for elucidating BSC2's complex cellular roles:
CRISPR-based approaches:
Implement CRISPRi/CRISPRa for precise temporal control of BSC2 expression
Use CRISPR screening to identify genetic interactions with BSC2
Apply base editing for targeted mutation of specific BSC2 residues
Implement CRISPR-based imaging to track BSC2 localization in live cells
Single-cell technologies:
Apply single-cell RNA-seq to capture heterogeneity in BSC2 response
Use single-cell proteomics to identify cell-specific BSC2 effects
Implement microfluidic approaches for real-time phenotypic tracking
Develop reporter systems visible at the single-cell level
Advanced imaging:
Apply super-resolution microscopy to study BSC2 localization
Use correlative light and electron microscopy for ultrastructural context
Implement live-cell imaging with fluorescent translational reporters
Apply expansion microscopy to resolve subcellular BSC2 distributions
Multi-omics integration:
Combine transcriptomics, proteomics, and metabolomics data
Implement spatial transcriptomics for biofilm structure-function relationships
Develop computational models integrating multiple data types
Apply machine learning for pattern recognition across complex datasets
These approaches can help overcome current limitations in understanding BSC2 function, particularly regarding its subcellular localization, temporal dynamics, and heterogeneous effects within cellular populations .
BSC2 research holds significant potential for applications in various fields:
Antifungal drug development:
Target BSC2 to overcome resistance in pathogenic fungi
Develop combination therapies targeting BSC2-dependent pathways
Create screening platforms to identify compounds affecting BSC2 function
Design BSC2 inhibitors as adjuvants for existing antifungals
Biofilm control strategies:
Apply BSC2-related insights to disrupt harmful fungal biofilms
Develop biofilm prevention approaches for medical devices
Create biotechnological tools for controlled biofilm formation
Design targeted approaches for biofilm dispersal
Protein production optimization:
Exploit BSC2's role in translation to enhance recombinant protein yield
Optimize stop codon readthrough for specific applications
Develop strains with controlled translational fidelity
Enhance production of difficult-to-express proteins
Cell wall engineering:
Modify cell surface properties for industrial applications
Enhance cell resistance to industrial processing conditions
Develop strains with tailored adhesion properties
Create specialized cell surfaces for biotechnological applications
While BSC2 has been primarily studied in S. cerevisiae, the mechanisms it influences (drug resistance, biofilm formation, translation) are broadly relevant across fungal species, including pathogenic ones. Translating research findings to species like Candida or Aspergillus could lead to significant medical advances in antifungal therapy .
Synthetic biology offers powerful approaches to expand BSC2 research:
Modular domain engineering:
Create chimeric proteins combining BSC2 domains with other functional modules
Develop synthetic BSC2 variants with enhanced or novel functions
Design orthogonal BSC2-based regulatory systems
Implement domain swapping to test functional hypotheses
Synthetic genetic circuits:
Design feedback loops involving BSC2 for precise regulation
Create oscillatory systems to study temporal aspects of BSC2 function
Implement synthetic promoters responsive to BSC2-regulated pathways
Develop bistable switches for controlled biofilm formation
Minimal system reconstitution:
Identify minimal components required for BSC2-mediated phenotypes
Reconstitute these systems in heterologous hosts
Implement bottom-up approaches to understand complex phenotypes
Create simplified model systems for mechanistic studies
Directed evolution:
Develop selection schemes for enhanced BSC2 functions
Evolve BSC2 variants with specialized properties
Apply continuous evolution systems for rapid optimization
Implement deep mutational scanning to comprehensively map function
These approaches could help isolate and enhance specific BSC2 functions for both fundamental research and applied biotechnology. For example, creating synthetic variants of BSC2 with enhanced ability to regulate cell wall properties could lead to strains with improved industrial characteristics or novel biotechnological applications .